These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8862937)

  • 1. LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow.
    Packard CJ
    Curr Med Res Opin; 1996; 13(7):379-90. PubMed ID: 8862937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction.
    Tornvall P; Karpe F; Carlson LA; Hamsten A
    Atherosclerosis; 1991 Sep; 90(1):67-80. PubMed ID: 1799399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.
    Griffin BA; Freeman DJ; Tait GW; Thomson J; Caslake MJ; Packard CJ; Shepherd J
    Atherosclerosis; 1994 Apr; 106(2):241-53. PubMed ID: 8060384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein atherogenicity: an overview of current mechanisms.
    Griffin BA
    Proc Nutr Soc; 1999 Feb; 58(1):163-9. PubMed ID: 10343354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic lipoprotein particles in atherosclerosis.
    Carmena R; Duriez P; Fruchart JC
    Circulation; 2004 Jun; 109(23 Suppl 1):III2-7. PubMed ID: 15198959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women have a larger and less atherogenic low density lipoprotein particle size than men.
    Nikkilä M; Pitkäjärvi T; Koivula T; Solakivi T; Lehtimäki T; Laippala P; Jokela H; Lehtomäki E; Seppä K; Sillanaukee P
    Atherosclerosis; 1996 Jan; 119(2):181-90. PubMed ID: 8808495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the response of serum lipoproteins to fenofibrate between women and men with primary hypercholesterolaemia.
    Sudhop T; Lütjohann D; Ratman C; von Bergmann J; von Bergmann K
    Eur J Clin Pharmacol; 1996; 50(5):365-9. PubMed ID: 8839657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.
    Badiou S; Merle De Boever C; Dupuy AM; Baillat V; Cristol JP; Reynes J
    Atherosclerosis; 2004 Feb; 172(2):273-9. PubMed ID: 15019537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria.
    Deighan CJ; Caslake MJ; McConnell M; Boulton-Jones JM; Packard CJ
    Atherosclerosis; 2001 Jul; 157(1):211-20. PubMed ID: 11427223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherogenicity of low-density lipoproteins (LDL). A problem of quantity or quality?].
    Dejager S; Turpin G
    Presse Med; 1995 Dec; 24(38):1772-6. PubMed ID: 8545426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
    Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease.
    Jaakkola O; Solakivi T; Tertov VV; Orekhov AN; Miettinen TA; Nikkari T
    Coron Artery Dis; 1993 Apr; 4(4):379-85. PubMed ID: 8261211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small LDL and its clinical importance as a new CAD risk factor: a female case study.
    Superko HR; Nejedly M; Garrett B
    Prog Cardiovasc Nurs; 2002; 17(4):167-73. PubMed ID: 12417832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.